BioHarvest Sciences Inc. BioHarvest Sciences Inc.

BioHarvest Sciences Inc.

BHSC

Rangering i aksjer #21521
Based in Vancouver, Canada, BioHarvest Sciences Inc. and its subsidiaries are... Based in Vancouver, Canada, BioHarvest Sciences Inc. and its subsidiaries are active globally, including in Israel, providing nutraceutical products derived from super fruits and cannabis. The company employs a proprietary plant cell growth technology that effectively produces desired active secondary metabolites without needing to cultivate the entire plant. BioHarvest is responsible for the design, development, production, and commercialization of Vinia, a red grape powder nutraceutical, alongside its medical cannabis offerings.
Aksjekurs
$5.83
Sist synkronisert: 2025-02-14
Markedsverdi
$101.10M
Endring (1 dag)
4.17%
Endring (1 år)
-5.89%
Land
CA
Handel BioHarvest Sciences Inc. (BHSC)

Kategori

Healthcare
EPS for BioHarvest Sciences Inc. (BHSC)
EPS per September 2024 TTM: $-1.20
Ifølge de siste økonomiske rapportene og aksjekursen til BioHarvest Sciences Inc. er selskapets nåværende EPS (TTM) $-1.20. Ved slutten av 2022 hadde selskapet en EPS på $-0.86, en økning sammenlignet med EPS-en i 2021 som var $-0.79.
EPS-historikk for BioHarvest Sciences Inc. fra 2014 til 2026
EPS ved slutten av hvert år
År EPS Endre
2026 (TTM) $-1.20 29.03%
2023 $-0.93 8.14%
2022 $-0.86 8.86%
2021 $-0.79 16.18%
2020 $-0.68 -62.22%
2019 $-1.80 -89.29%
2018 $-16.80 6,891.26%
2017 $-0.24 2,403.13%
2016 $-0.01 -41.82%
2015 $-0.02 -53.26%
2014 $-0.04 0.00%
EPS for lignende selskaper eller konkurrenter